| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 133.41B | 151.85B | 129.54B | 126.72B | 121.34B | 101.27B |
| Gross Profit | 32.14B | 35.37B | 30.70B | 27.81B | 26.86B | 24.65B |
| EBITDA | 15.56B | 18.28B | 14.32B | 12.72B | 14.30B | 10.98B |
| Net Income | 10.36B | 12.47B | 9.55B | 8.50B | 6.09B | 6.84B |
Balance Sheet | ||||||
| Total Assets | 81.68B | 93.25B | 83.33B | 77.37B | 66.30B | 62.64B |
| Cash, Cash Equivalents and Short-Term Investments | 13.65B | 8.23B | 18.77B | 22.03B | 8.73B | 13.41B |
| Total Debt | 26.50B | 26.50B | 26.50B | 26.50B | 18.50B | 18.50B |
| Total Liabilities | 35.29B | 40.19B | 37.61B | 37.02B | 30.54B | 29.89B |
| Stockholders Equity | 46.39B | 53.06B | 45.72B | 40.34B | 35.77B | 32.75B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.27B | 1.05B | 9.43B | -1.54B | -2.50B |
| Operating Cash Flow | 0.00 | -5.20B | 1.16B | 9.50B | -1.47B | -2.49B |
| Investing Cash Flow | 0.00 | -108.00M | -152.00M | -192.00M | -85.00M | -20.00M |
| Financing Cash Flow | 0.00 | -5.23B | -4.27B | 3.99B | -3.13B | -3.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥175.32B | 12.34 | ― | 2.33% | 4.90% | 11.86% | |
66 Neutral | ¥202.37B | 14.07 | 20.50% | 1.49% | 3.01% | -18.79% | |
63 Neutral | ¥271.18B | 19.57 | 23.24% | 2.13% | 17.23% | 30.45% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥114.58B | 8.03 | 15.81% | 2.93% | 12.51% | 12.42% | |
57 Neutral | ¥63.52B | 19.18 | ― | 2.89% | 4.32% | 11.25% | |
52 Neutral | ¥42.42B | 25.79 | ― | 0.45% | 23.11% | 8.31% |